Exos Asset Management’s Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 ATA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-12,500
Closed -$8K 830
2021
Q2
$8K Hold
12,500
﹤0.01% 785
2021
Q1
$7K Buy
+12,500
New +$11.9K 0.01% 401

Other funds holding ATA.WS

Exos Asset Management's ATA.WS Position: Q3 2021 in Review

Exos Asset Management sold out of Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 (ATA.WS) in Q3 2021, closing a stake of 12,500 shares — an estimated $8K sold.

Exos Asset Management first reported a position in ATA.WS in Q1 2021 and held it in 2 quarters. The position peaked at $8K in Q2 2021. 25 funds tracked by Wall St. Rank hold ATA.WS as of Q3 2021.

  • Exos Asset Management reported no remaining Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 position as of Q3 2021 after selling out during the quarter.
  • Exos Asset Management sold 12,500 Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 shares in Q3 2021, an estimated $8K.
  • Exos Asset Management first reported a position in Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 in Q1 2021 and held it in 2 quarters.
  • Exos Asset Management's Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 position peaked at $8K in Q2 2021.
  • 25 funds tracked by Wall St. Rank held Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.